Tetra Bio-Pharma Closes the Acquisition of Panag Pharma
May 01, 2019 17:04 ET
|
Tetra Bio-Pharma Inc
OTTAWA, May 01, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company"), a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased...
Tetra Santé Naturelle annonce l'arrivée de 20 conteneurs de Hemp Energy Drink au Canada
April 30, 2019 08:00 ET
|
Tetra Bio-Pharma Inc
OTTAWA, 30 avr. 2019 (GLOBE NEWSWIRE) -- Tetra Santé Naturelle, une filiale de Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), annonce l’arrivée de vingt (20) conteneurs, soit plus de 1,7...
Tetra Natural Health Announces The Arrival of 20 containers of Hemp Energy Drink in Canada
April 30, 2019 08:00 ET
|
Tetra Bio-Pharma Inc
OTTAWA, April 30, 2019 (GLOBE NEWSWIRE) -- Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), announces the arrival of twenty (20) containers, or more than...
Tetra Bio-Pharma and Altus Formulation Sign Joint Venture Agreement for Cannabinoid Drug Product Development
April 29, 2019 06:30 ET
|
Tetra Bio-Pharma Inc
OTTAWA, April 29, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or “TBP”), (TSX VENTURE: TBP) (OTCQB: TBPMF), and Altus Formulation Inc. (“Altus”) today announced the signing of a Joint...
Les actionnaires de Tetra Bio-Pharma approuvent l’acquisition de Panag Pharma
April 18, 2019 17:50 ET
|
Tetra Bio-Pharma Inc
OTTAWA, 18 avr. 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (« Tetra » ou la « Société ») (TSX-V : TBP) (OTCQB : TBPMF) est heureuse d’annoncer qu’à l’occasion d’une assemblée extraordinaire des...
Tetra Bio-Pharma Shareholders Approve the Acquisition of Panag Pharma
April 18, 2019 17:50 ET
|
Tetra Bio-Pharma Inc
OTTAWA, April 18, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V: TBP) (OTCQB: TBPMF), is pleased to announce that, at a special meeting of shareholders held today...
Tetra Bio-Pharma et Ovensa s’engagent à collaborer pour lutter contre le cancer du cerveau
April 11, 2019 06:30 ET
|
Tetra Bio-Pharma Inc; Ovensa
OTTAWA, 11 avr. 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (« Tetra » ou la « Société ») (TSX-V : TBP) (OTCQB : TBPMF), a annoncé aujourd’hui la conclusion d’une entente de collaboration avec la...
Tetra Bio-Pharma and Ovensa Will Engage in a Collaboration to Tackle Brain Cancer
April 11, 2019 06:30 ET
|
Tetra Bio-Pharma Inc; Ovensa
OTTAWA, April 11, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V: TBP) (OTCQB: TBPMF), today announced that it has entered into a collaboration agreement with...
Tetra Bio-Pharma reprend son programme d’essai clinique de phase 3
April 09, 2019 09:57 ET
|
Tetra Bio-Pharma Inc
OTTAWA, 09 avr. 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (« Tetra » ou la « société ») (TSX-V: TBP) (OTCQB: TBPMF) a annoncé aujourd’hui qu’elle est prête à reprendre son programme d’essai...
Tetra Bio-Pharma Resumes its Phase 3 Clinical Trial Program
April 09, 2019 06:30 ET
|
Tetra Bio-Pharma Inc
OTTAWA, April 09, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V: TBP) (OTCQB: TBPMF), today announced it is ready to resume its Phase 3 clinical program in...